Why antibiotics should not be used to treat Shiga toxin-producing Escherichia coli infections

Acute peritoneal dialysis, complications and outcomes in 389 children with STEC-HUS: a multicenter experience

(2021) Paula A. Coccia et al.   PEDIATRIC NEPHROLOGY

Hemoconcentration and predictors in Shiga toxin-producing E. coli-hemolytic uremic syndrome (STEC-HUS)

(2021) Sebastian Loos et al.   PEDIATRIC NEPHROLOGY

Prevalence of Detection of Clostridioides difficile Among Asymptomatic Children

(2021) Sarah R. Tougas et al.   JAMA Pediatrics

Bloody Diarrhea and Shiga Toxin–Producing Escherichia coli Hemolytic Uremic Syndrome in Children: Data from the ItalKid-HUS Network

(2021) Gianluigi Ardissino et al.   JOURNAL OF PEDIATRICS

Hemolytic uremic syndrome caused by Shiga toxin–producing Escherichia coli in children: incidence, risk factors, and clinical outcome

(2020) Elisa Ylinen et al.   PEDIATRIC NEPHROLOGY

Predicting Hemolytic Uremic Syndrome and Renal Failure in Shiga Toxin-Producing Escherichia coli Infected Children

(2019) Ryan S McKee et al.   CLINICAL INFECTIOUS DISEASES

Particulate Shiga Toxin 2 in Blood is Associated to the Development of Hemolytic Uremic Syndrome in Children

(2019) Maurizio Brigotti et al.   THROMBOSIS AND HAEMOSTASIS

Strength of the association between antibiotic use and hemolytic uremic syndrome following Escherichia coli O157:H7 infection varies with case definition

(2018) Gillian A.M. Tarr et al.   INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY

Multiplex Nucleic Acid Amplification Testing to Diagnose Gut Infections

(2018) Neil W. Anderson et al.   GASTROENTEROLOGY CLINICS OF NORTH AMERICA

Case definitions of hemolytic uremic syndrome following Escherichia coli O157:H7 infection vary in validity

(2018) Gillian A.M. Tarr et al.   INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY

C septicum Complicating Hemolytic Uremic Syndrome: Survival Without Surgical Intervention

(2017) Rachel M. Engen et al.   PEDIATRICS

Shiga Toxin–ProducingEscherichia coliInfection, Antibiotics, and Risk of Developing Hemolytic Uremic Syndrome: A Meta-analysis

(2016) Stephen B. Freedman et al.   CLINICAL INFECTIOUS DISEASES

Multicenter Evaluation of the BD Max Enteric Bacterial Panel PCR Assay for Rapid Detection of Salmonella spp., Shigella spp., Campylobacter spp. (C. jejuni and C. coli), and Shiga Toxin 1 and 2 Genes

(2015) S. M. Harrington et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Postdiarrheal Hemolytic Uremic Syndrome in United States Children: Clinical Spectrum and Predictors of In-Hospital Death

(2015) Rajal K. Mody et al.   JOURNAL OF PEDIATRICS

A Novel Mechanism of Bacterial Toxin Transfer within Host Blood Cell-Derived Microvesicles

(2015) Anne-lie Ståhl et al.   PLoS Pathogens

Enhanced Virulence of the Escherichia coli O157:H7 Spinach-Associated Outbreak Strain in Two Animal Models Is Associated with Higher Levels of Stx2 Production after Induction with Ciprofloxacin

(2014) T. Zangari et al.   INFECTION AND IMMUNITY

Multiple-Aetiology Enteric Infections Involving Non-O157 Shiga Toxin-ProducingEscherichia coli- FoodNet, 2001-2010

(2014) R. E. Luna-Gierke et al.   Zoonoses and Public Health

Ciprofloxacin reduces the risk of hemolytic uremic syndrome in patients with Escherichia coli O104:H4-associated diarrhea

(2013) H. F. Geerdes-Fenge et al.   INFECTION

Infections in Pediatric Postdiarrheal Hemolytic Uremic Syndrome

(2012) Rajal K. Mody et al.   ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE

Risk Factors for the Hemolytic Uremic Syndrome in Children Infected With Escherichia coli O157:H7: A Multivariable Analysis

(2012) C. S. Wong et al.   CLINICAL INFECTIOUS DISEASES

Diarrhea Etiology in a Pediatric Emergency Department: A Case Control Study

(2012) Donna M. Denno et al.   CLINICAL INFECTIOUS DISEASES

Association Between Azithromycin Therapy and Duration of Bacterial Shedding Among Patients With Shiga Toxin–Producing Enteroaggregative Escherichia coli O104:H4

(2012) Martin Nitschke et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Does Levofloxacin Induce Hemolytic Uremic Syndrome in Patients Infected with Verotoxin-Producing Escherichia coli O157 Infections?

(2012) Kenji Ohnishi et al.   JAPANESE JOURNAL OF INFECTIOUS DISEASES

Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study

(2012) J. Menne et al.   BMJ-British Medical Journal

Early Volume Expansion During Diarrhea and Relative Nephroprotection During Subsequent Hemolytic Uremic Syndrome

(2011) Christina A. Hickey   ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE

A 2-YEAR-OLD BOY WITH HEMOLYTIC UREMIC SYNDROME AND PNEUMOCEPHALUS

(2011) Sarah E. Martin et al.   BRAIN PATHOLOGY

An Epidemiologic Surveillance of Shiga-like Toxin-producing Escherichia coli Infection in Argentinean Children

(2011) Eduardo L. López et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Antibiotic Treatment of Escherichia coli O157 Infection and the Risk of Hemolytic Uremic Syndrome, Minnesota

(2011) Kirk E. Smith et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Acute dialysis-associated peritonitis in children with D+ hemolytic uremic syndrome

(2011) Marta Adragna et al.   PEDIATRIC NEPHROLOGY

Hemolytic Uremic Syndrome After an Escherichia coli O111 Outbreak

(2010) Emily W. Piercefield et al.   ARCHIVES OF INTERNAL MEDICINE

Role and clinical course of verotoxigenic Escherichia coli infections in childhood acute diarrhoea in Argentina

(2009) M. A. Rivero et al.   JOURNAL OF MEDICAL MICROBIOLOGY